Skip to main content

Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013

    Basic Details
    Date Posted
    Status
    Complete
    Medical Product
    new molecular entities (NMEs)
    Description

    In this report we described baseline characteristics and the duration of follow-up time among new users of 20 new molecular entities (NMEs) approved in 2010, 38 NMEs approved in 2012, and 28 NMEs approved in 2013 by the U.S. Food and Drug Administration in the Sentinel Distributed Database (SDD).